I agree that this site is using cookies. You can find further informations here.
X
Heinzmann, Dominik
48  results:
Search for persons X
?
1

Applying the estimand and target trial frameworks to extern..:

Polito, Letizia ; Liang, Qixing ; Pal, Navdeep...
Frontiers in Pharmacology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Weighted Approach for Estimating Effects in Principal Strat..:

Kong, Shengchun ; Heinzmann, Dominik ; Lauer, Sabine.
Statistics in Biopharmaceutical Research.  , 2022
Link: https://doi.org/10.1080/..
 
?
3

Event-Free Survival in Patients with Early HER2-Positive Br..:

Swain, Sandra M. ; Macharia, Harrison ; Cortes, Javier...
Cancers.  14 (2022)  20 - p. 5051 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Real‐world data prognostic model of overall survival in pat..:

Julian, Cristina ; Machado, Robson J. M. ; Girish, Sandhya...
Cancer Reports.  5 (2022)  10 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
5

On Identification of the Principal Stratum Effect in Patien..:

Dukes, Oliver ; Van Lancker, Kelly ; Bornkamp, Björn...
Statistics in Biopharmaceutical Research.  13 (2021)  4 - p. 508-510 , 2021
Link: https://doi.org/10.1080/..
 
?
6

A pragmatic adaptive enrichment design for selecting the ri..:

Nguyen Duc, Anh ; Heinzmann, Dominik ; Berge, Claude.
Pharmaceutical Statistics.  20 (2020)  2 - p. 202-211 , 2020
Link: https://doi.org/10.1002/..
 
?
7

Integrating phase 2 into phase 3 based on an intermediate e..:

Rufibach, Kaspar ; Heinzmann, Dominik ; Monnet, Annabelle
Pharmaceutical Statistics.  19 (2019)  1 - p. 44-58 , 2019
Link: https://doi.org/10.1002/..
 
?
8

Development pathways for subcutaneous formulations of biolo..:

Zharkov, Artem ; Barton, Bettina ; Heinzmann, Dominik..
Expert Review of Precision Medicine and Drug Development.  7 (2019)  1 - p. 62-69 , 2019
Link: https://doi.org/10.1080/..
 
?
9

Clinical Pharmacokinetics of Vemurafenib:

Zhang, Weijiang ; Heinzmann, Dominik ; Grippo, Joseph F.
Clinical Pharmacokinetics.  56 (2017)  9 - p. 1033-1043 , 2017
Link: https://doi.org/10.1007/..
 
?
10

HannaH phase III randomised study: Association of total pat..:

Jackisch, Christian ; Hegg, Roberto ; Stroyakovskiy, Daniil...
European Journal of Cancer.  62 (2016)  - p. 62-75 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Population pharmacokinetic and exposure–response analysis f..:

Quartino, Angelica L. ; Hillenbach, Carina ; Li, Jing...
Cancer Chemotherapy and Pharmacology.  77 (2015)  1 - p. 77-88 , 2015
Link: https://doi.org/10.1007/..
 
?
12

Comparative pharmacokinetics of subcutaneous trastuzumab ad..:

Wynne, Chris J. ; Ellis-Pegler, Rod B. ; Waaka, Devonie S....
Cancer Chemotherapy and Pharmacology.  72 (2013)  5 - p. 1079-1087 , 2013
Link: https://doi.org/10.1007/..
 
?
13

A cross-sectional study of biotechnology awareness and teac..:

Vanderschuren, Hervé ; Heinzmann, Dominik ; Faso, Carmen...
New Biotechnology.  27 (2010)  6 - p. 822-828 , 2010
Link: https://doi.org/10.1016/..
 
?
14

EXTINCTION TIMES IN MULTITYPE MARKOV BRANCHING PROCESSES:

HEINZMANN, DOMINIK
Journal of Applied Probability.  46 (2009)  1 - p. 296-307 , 2009
Link: https://www.jstor.org/st..
 
?
15

Compound processes as models for clumped parasite data:

Heinzmann, Dominik ; Barbour, A.D. ; Torgerson, Paul R.
Mathematical Biosciences.  222 (2009)  1 - p. 27-35 , 2009
Link: https://doi.org/10.1016/..
 
1-15